Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
third rock ventures
2
×
ally bridge group
amgen
big data analytics
blackrock
boston
cancer
cancer drugs
casdin capital
cobimetinib
deals
diabetic nephropathy
eventide asset management
focal segmental glomerulosclerosis
goldfinch bio
investing
ipo
irving investors
jay ghosh
revolution medicines
roche
san francisco
san francisco blog main
san francisco top stories
sanofi
schroeder adveq
software
the column group
university of illinois
venture capital
warp drive bio
wellington management company
yonjin capital
What
drug
2
×
ipo
2
×
medicines
analysis
bio
biotech
bring
cancer
company
despite
develop
diseases
employing
family
genetic
goldfinch
hardest
hit
hottest
hunters
kidney
later
lead
million
new
proteins
raised
raises
ras
reels
research
revolution
studies
targets
Language
unset
Current search:
ipo
×
drug
×
" third rock ventures "
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer